LQDA: Liquidia Corp Company Profile & Statistics

About

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.

Info & Links

CEO

Roger A. Jeffs

Headquarters

419 DAVIS DRIVE, SUITE 100
MORRISVILLE, NC 27560, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

145

Liquidia Corp Statistics

Valuation Measures

Market Capitalization²

1.09B

Enterprise Value

888.33M

Enterprise Value/EBITDA(ttm)

-8.12

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

66.09

Price to Book(mrq)

9.34

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

63.18%

Operating Margin(ttm)

-801.89%

Profit Margin(ttm)

-816.79%

Return on Equity(ttm)

-163.21%

Return on Invested Capital(ttm)

-170.99%

Return on Assets(ttm)

-67.14%

Income Statement

Revenue(ttm)

15.61M

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

10.09M

EBITDA(ttm)³

-109.44M

Net Income Available to Common(ttm)

-119.48M

Diluted EPS(ttm)

-1.63

Share Statistics

Beta (5Y Monthly)

0.23

52-Week Change

73.99%

S&P 500 52-Week Change

25.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

84.64M

Dividend Yield

0.00%

Float⁴

59.16M

% Held by Insiders

30.10%

% Held by Institutions

64.54%

Balance Sheet

Total Cash(mrq)

204.37M

Total Cash Per Share(mrq)

2.41

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.33%

Quick Ratio(mrq)

6.33%

Book Value Per Share(mrq)

1.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.93

Free Cash Flow(ytd)

-76.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LQDA

Liquidia Corp

Liquidia Corp Profile